Placebo i.m. injection clinical trials

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

This study looks at how safe and effective two medicines, fingolimod and interferon beta-1a, are for young people aged 10-17 with multiple sclerosis (MS). It compares them to see which works best and is safest.